Bio Protocol
PrivateLast Round
Seed
Sep 17, 2025
Est. Valuation
$214.4M
Total Funding Raised
$7.19M
Company Overview
Bio Protocol operates in Crypto & Web3 and is based in Zug. Its latest recorded funding round was a Seed round in September 2025.
Bio Protocol is a decentralized science (DeSci) company that provides a blockchain-based platform for funding, developing, and commercializing biotechnology research through community-owned BioDAOs and AI-driven BioAgents.
Sector
Crypto & Web3
Verticals
Biotechnology, DAOs, DeFi, Blockchain Infrastructure, Drug Discovery
Business Model
B2B2C
Customer Profile
Marketplace Commission, Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bio Protocol Comparables
Compare Bio Protocol with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Molecule | 88% | |
| ValleyDAO | 73% | |
| LabDAO | 71% |
For institutional investors. Book with your work email.
Bio Protocol Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 17, 2025 | ||||
| Token Sale | Nov 14, 2024 | ||||
| Token Sale | Nov 14, 2024 | ||||
| Strategic | Nov 8, 2024 | ||||
| Token Sale | Aug 1, 2024 | ||||
Token Sale | Jun 1, 2024 |
For institutional investors. Book with your work email.
Bio Protocol Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maelstrom | Seed |
| ID Theory | Token Sale |
| Panga Capital | Token Sale, Seed |
| L1 Digital | Token Sale |
| Moonrock Capital | Seed |
| Prelude | Token Sale |
| Zee Prime Capital | Token Sale, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 38% MoM, reaching 33K.
- Feb 11, 2026
Grew 15% QoQ, from 26 to 30 employees.
For institutional investors. Book with your work email.
Bio Protocol Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bio Protocol's valuation, stock price, and market status.
Is Bio Protocol a public or private company?
Bio Protocol is a private company.
What is the current stock price of Bio Protocol?
Bio Protocol is a private company, so its shares have no public market price. Caplight tracks Bio Protocol's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bio Protocol worth (valuation)?
Bio Protocol's valuation is estimated at $214.4M based on funding round data.
Can I buy Bio Protocol stock?
Bio Protocol shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bio Protocol's last funding round?
Bio Protocol's most recent funding round was Seed on September 17, 2025.
Who are the main investors in Bio Protocol?
Key investors in Bio Protocol include Maelstrom.
Will Bio Protocol IPO soon?
No public IPO plans have been announced for Bio Protocol.
How can I track Bio Protocol secondary market activity?
Caplight tracks bids, offers, and trades in Bio Protocol's shares on secondary markets.